Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Clinical trial NCT04886063 · TERMINATED

Trial details

NCT number: NCT04886063
Sponsor: LeonaBio
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-06-30
Primary completion: 2024-10-23
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.